Evelo Biosciences, Inc. Uncategorized Contracts & Agreements
14 Contracts & Agreements
- Letter Agreement with Balkrishan (Simba) Gill, Ph.D., dated August (Filed With SEC on August 21, 2023)
- Letter Agreement, dated February 1, 2023, by and between Evelo Biosciences, Inc. and Marella Thorell (Filed With SEC on March 16, 2023)
- Offer Letter, dated (Filed With SEC on November 14, 2022)
- Offer Letter (Filed With SEC on August 11, 2022)
- Offer Letter (Filed With SEC on August 11, 2022)
- Fourth Amendment, dated of June 16, 2021, to the (Filed With SEC on June 17, 2021)
- Amendment dated April 9, 2021 to Letter Agreement between Evelo Biosciences, Inc. and David R. Epstein (Filed With SEC on April 29, 2021)
- Letter Agreement, dated September 16, 2019, between Evelo Biosciences, Inc. and David R. Epstein, as amended (Filed With SEC on October 30, 2020)
- Amendment No. 1 to Exclusivity and Commitment Agreement between Evelo Biosciences, Inc. and Biose Industrie, dated as of August 1, 2019 (Filed With SEC on November 5, 2019)
- Letter Agreement, dated September 16, 2019, between Evelo Biosciences, Inc. and David R. Epstein (Filed With SEC on September 18, 2019)
- Exclusivity and Commitment Agreement between Biose and the Registrant, dated February 15, 2018 (Filed With SEC on April 30, 2018)
- Offer Letter between the Registrant and Balkrishan (Simba) Gill, Ph.D., dated June 25, 2015, as amended on April 26, 2018 (Filed With SEC on April 30, 2018)
- Offer Letter between the Registrant and Mark Bodmer, Ph.D., dated October 6, 2015 (Filed With SEC on April 30, 2018)
- Exclusivity and Commitment Agreement between Biose and the Registrant, dated February 15, 2018 (Filed With SEC on April 13, 2018)
